We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine

By LabMedica International staff writers
Posted on 26 Sep 2024
Print article
Image: International expert meeting for trends and innovations in laboratory medicine - the MEDICA LABMED FORUM at MEDICA (Photo courtesy of Constanze Tillmann/Messe Düsseldorf)
Image: International expert meeting for trends and innovations in laboratory medicine - the MEDICA LABMED FORUM at MEDICA (Photo courtesy of Constanze Tillmann/Messe Düsseldorf)

At MEDICA (Düsseldorf, Germany), the world’s premier trade fair for the healthcare industry and medical technology sector, this year’s event (November 11–14) will focus on the most exciting medical advancements. Professional forums and their accompanying stage programs will delve into health IT, medical technology trends, healthcare policy, and laboratory medicine. Among the highlights is the MEDICA LABMED FORUM, known for its informative lectures and expert panel discussions, which has become a key feature of the MEDICA program. Around 6,000 companies have secured their spots at MEDICA 2024 and COMPAMED 2024, the concurrent supplier trade fair. Last year, both events together attracted a total of 83,000 visitors.

This year, the focus is on massive digitalization, networking, big data applications, and artificial intelligence (AI), collectively referred to as "Lab 4.0." On November 11, the opening day of MEDICA 2024, the MEDICA LABMED FORUM will address the hot topic of digitalization and AI. The morning session will concentrate on the shortage of skilled personnel, a pressing issue in laboratory medicine. Panelists will explore how automation and digitalization could help resolve this crisis. The afternoon session will shift to AI and big data tools that are either currently available or in development. Discussions will cover image recognition through deep learning, now standard for automated leucogram analysis, and the developmental state of machine learning for handling the vast multivariate data sets in laboratory diagnostics. A key question will be whether large language models can clarify complex lab findings and whether AI is making us smarter or dumber.

On the second day, discussions will focus on developments in laboratory medicine regarding cardiovascular diseases and cancer, the leading causes of mortality in the Western world. The cardiology section will highlight congenital heart defects, which are increasingly surgically correctable in childhood and are becoming more prominent in adult medicine due to extended life expectancy. Speakers will provide a clinical perspective and demonstrate the potential of machine learning in modern data evaluation. The afternoon session will cover highly sensitive cancer diagnostics using blood, known as “liquid biopsy,” which is revolutionizing oncology by allowing closer monitoring of tumor progression than conventional tissue biopsies. The session will also explore new techniques like analyzing methylation profiles for early detection of hereditary cancer forms and single-cell analysis using microfluidics.

On Young Scientists' Day, the next generation of researchers will present their perspectives on the future of laboratory medicine, offering insights into the latest advancements and challenges. Topics will include wearables for continuous diagnostic monitoring and the ongoing shortage of skilled personnel. The afternoon will feature discussions on personalized therapy based on individual laboratory parameters, the integration of laboratory and imaging diagnostics, and the role of AI in these fields.

The forum’s final day traditionally focuses on diagnostic research institutes and companies looking to introduce new applications in laboratory medicine. The theme for 2024 will center on aging, with sessions examining pathophysiology, diagnostics, and treatment. Topics will include the genetic and epigenetic factors influencing biological aging, protein misfolding as a basis for neurodegenerative diseases like Alzheimer's and Parkinson's, and the role of gut microbiota in strokes. As the forum’s "grand finale," discussions will address theories and practical approaches to slowing the aging process, such as anti-aging drugs, the effects of anti-inflammatory agents, environmental influences on aging in the central nervous system, and methods for repairing nervous system lesions.

Related Links:
MEDICA

New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Unit-Dose Packaging solution
HLX
New
Clostridium Difficile Assay
Revogene C. Difficile
New
Bordetella Pertussis ELISA
NovaLisa Bordetella Pertussis IgA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: A scanning electron microscope image of chiral gold nanoparticles developed for a new microfluidic chip (Matter, 2024; DOI: 10.1016/j.matt.2024.09.005)

Simple Blood Draw Helps Diagnose Lung Cancer 10 Times Faster

Once dismissed as cellular waste, exosomes—tiny vesicles released by cells containing proteins, DNA, or RNA fragments—have emerged as vital players in cell-to-cell communication over the past decade.... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.